Imbalance of Molecular Module of TINCR-miR-761 Promotes the Metastatic Potential of Early Triple Negative Breast Cancer and Partially Offsets the Anti-Tumor Activity of Luteolin

References

• Naderi N, Peymani M, Ghaedi K. The protective role of rs56103835 against breast cancer onset in the Iranian population. Mol Genet Genomic Med. 2019;7(3):e540. doi:10.1002/mgg3.54030706682
   PubMed Web of Science ®Google Scholar
• Sharma R. Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from global burden of disease study 2016. Breast Cancer. 2019;26(4):428–445. doi:10.1007/s12282-018-00941-430604398
   PubMed Web of Science ®Google Scholar
• Beckers RK, Selinger CI, Vilain R, et al. Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome. Histopathology. 2016;69(1):25–34. doi:10.1111/his.1290426588661
   PubMed Web of Science ®Google Scholar
• Lee J, Lim B, Pearson T, et al. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer. Breast Cancer Res Treat. 2019;175(2):339–351. doi:10.1007/s10549-019-05166-330826934
   PubMed Web of Science ®Google Scholar
• Zhang G, Li H, Sun R, et al. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2. J Cell Mol Med. 2019;23(5):3271–3279. doi:10.1111/jcmm.1421330825262
   PubMed Web of Science ®Google Scholar
• Lin D, Kuang G, Wan J, et al. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of beta-catenin expression. Oncol Rep. 2017;37(2):895–902. doi:10.3892/or.2016.531127959422
   PubMed Web of Science ®Google Scholar
• Zhang G, Lan Y, Xie A, et al. Comprehensive analysis of long noncoding RNA (lncRNA)-chromatin interactions reveals lncRNA functions dependent on binding diverse regulatory elements. J Biol Chem. 2019;294(43):15613–15622. doi:10.1074/jbc.RA119.00873231484726
   PubMed Web of Science ®Google Scholar
• Wong L, Huang YA, You ZH, Chen ZH, Cao MY. LNRLMI linear neighbour representation for predicting lncRNA-miRNA interactions. J Cell Mol Med. 2020;24(1):79–87. doi:10.1111/jcmm.1458331568653
   PubMed Web of Science ®Google Scholar
• Wang J, Ding Y, Wu Y, Wang X. Identification of the complex regulatory relationships related to gastric cancer from lncRNA-miRNA-mRNA network. J Cell Biochem. 2020;121(1):876–887. doi:10.1002/jcb.2933231452262
   PubMed Web of Science ®Google Scholar
• Jin C, Yan B, Lu Q, Lin Y, Ma L. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development. Tumour Biol. 2016;37(6):7383–7394. doi:10.1007/s13277-015-4605-626676637
   PubMedGoogle Scholar
• Li S, Zhou J, Wang Z, Wang P, Gao X, Wang Y. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Biomed Pharmacother. 2018;104:451–457. doi:10.1016/j.biopha.2018.05.05629793177
   PubMed Web of Science ®Google Scholar
• Xu S, Kong D, Chen Q, Ping Y, Pang D. Oncogenic long noncoding RNA landscape in breast cancer. Mol Cancer. 2017;16(1):129. doi:10.1186/s12943-017-0696-628738804
   PubMed Web of Science ®Google Scholar
• Abhishek S, Palamadai Krishnan S. Epidermal differentiation complex: a review on its epigenetic regulation and potential drug targets. Cell J. 2016;18(1):1–6. doi:10.22074/cellj.2016.398027054112
   PubMed Web of Science ®Google Scholar
• Guo GC, Wang JX, Han ML, Zhang LP, Li L. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Cell Oncol (Dordr). 2017;40(2):157–166. doi:10.1007/s13402-016-0312-628054302
   PubMed Web of Science ®Google Scholar
• Jagadish N, Devi S, Gupta N, Suri V, Suri A. Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells in vitro and in vivo. Tumour Biol. 2020;42(4):1010428320914477. doi:10.1177/101042832091447732342732
   PubMedGoogle Scholar
• Xu TP, Liu XX, Xia R, et al. SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer. Oncogene. 2015;34(45):5648–5661. doi:10.1038/onc.2015.1825728677
   PubMed Web of Science ®Google Scholar
• Han Y, Sun G. Overexpression of lncRNA TINCR is associated with high-grade, invasive, and recurring tumors, and facilitates proliferation in vitro and in vivo of urothelial carcinoma of the bladder. Urol Oncol. 2020;38(9):738 e731–738 e738. doi:10.1016/j.urolonc.2019.12.026
   Web of Science ®Google Scholar
• Dong H, Hu J, Zou K, et al. Activation of LncRNA TINCR by H3K27 acetylation promotes trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast cancer. Mol Cancer. 2019;18(1):3. doi:10.1186/s12943-018-0931-930621694
   PubMed Web of Science ®Google Scholar
• Yan A, Yang C, Chen Z, Li C, Cai L. MiR-761 promotes progression and metastasis of non-small cell lung cancer by targeting ING4 and TIMP2. Cell Physiol Biochem. 2015;37(1):55–66. doi:10.1159/00043033326278569
   PubMedGoogle Scholar
• Sun X, Hou H, Li K, Zheng M. microRNA-761 regulates glycogen synthase kinase 3beta expression and promotes the proliferation and cell cycle of human gastric cancer cells. Oncol Lett. 2018;16(3):3459–3464. doi:10.3892/ol.2018.913330127949
   PubMed Web of Science ®Google Scholar
• Liu Y, Du Y, Hu X, Zhao L, Xia W. Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer. BMC Cancer. 2018;18(1):367. doi:10.1186/s12885-018-4255-329614984
   PubMed Web of Science ®Google Scholar
• Zheng J, Huang Y, Li Y, et al. lncRNA-TINCR functions as a competitive endogenous RNA to regulate the migration of mesenchymal stem cells by sponging miR-761. Biomed Res Int. 2020;2020:9578730.32185226
   PubMed Web of Science ®Google Scholar
• Bian D, Shi W, Shao Y, Li P, Song G. Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma. Am J Transl Res. 2017;9(3):1509–1520.28386376
   PubMed Web of Science ®Google Scholar
• Zhang G, Wang Q, Zhang X, Ding Z, Liu R. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis. Biomed Pharmacother. 2019;118:109309. doi:10.1016/j.biopha.2019.10930931545237
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang J, Li C, et al. LncRNA HOXA11-AS accumulation-induced microRNA-761 downregulation regulates cell growth by targeting TRIM29 in papillary thyroid cancer. Am J Transl Res. 2019;11(11):6826–6837.31814890
   PubMed Web of Science ®Google Scholar
• Wang D, Chen Y, Liu M, et al. The long noncoding RNA Arrl1 inhibits neurite outgrowth by functioning as a competing endogenous RNA during neuronal regeneration in rats. J Biol Chem. 2020;295(25):8374–8386. doi:10.1074/jbc.RA119.01191732336677
   PubMed Web of Science ®Google Scholar